Semaglutide also helps increase satiety and help you feel fuller longer
There's really no one-size-fits-all answer, which is why there's so much conflicting evidence
General peptide injection guidance applies as well, since the subcutaneous technique is consistent across most injectable peptides
Notably, no government drug regulatory agency across the world had approved for the use of any compound incorporating the Melanotan II peptide by 2010 Historical Development Melanotan II was first developed at the University of Arizona
Not required for most people: If you are healthy aside from weight concerns, have no chronic conditions, are not taking other medications that interact with GLP-1s, and are tolerating treatment well, you may not benefit from routine lab testing
Now-famous Ozempic (semaglutide) was initially approved in 2017 and Mounjaro (tirzepatide) in 2022, both of which are the more commonly used GLP-1s in recent years